Exhibit
10.30


 


Intercompany Loan Agreement


 


between


 


Bruker BioSpin GmbH


Silberstreifen 4,


76287 Rheinstetten


 


as Lender


 


and


 


Bruker EAS GmbH


Ehrichstrasse 10,


63450 Hanau


 


as Borrower


 


1.             The Loan


 


1.1           The Lender agrees to grant to the
Borrower until further notice a credit line in the amount of EUR 1.500.000,00
(EUR One Million Five hundred Thousand).


 


1.2           The payment can be executed in total
or in partial amounts up to the nominal amount until prior written notice.


 


1.3           The obligation of the Borrower to
repay the Loan and/or interest according to this agreement is subject to the
condition that such payments do not cause a short fall of the net assets of the
Borrower below the amount of the stated capital protected pursuant to §§ 30, 31
German Act on Limited Liability Companies (GmbHG) or any increase of an
existing shortfall below such amount. To the extent the Borrower can capitalize
hidden reserves by selling assets and thereby prevent an infringement of the
net assets required to maintain the stated capital, it shall be obliged to sell
such assets at its choice; any assets required for the business as a going
concern shall however be released from this obligation.


 


2.             Interest


 


2.1           Interest shall be computed on the
basis of the actual number of days elapsed in a 360-day-year. The interest rate
is equal to 3.5% p. a..


 


2.2           Any interest shall become due and
payable at the end of each quarter.


 


3.             Repayment


 


The
repayment of the loan in the amount of the actual borrowing will be due on June 30th of each calendar year.


 

















 


4.             Optional Repayments


 


The
Borrower shall be entitled to repay the Loan at all times without premium or
penalty upon prior written notice to the Lender, either in whole or in part.


 


5.             Securities


 


The
Loan is secured by a Comfort Letter of Bruker Corporation, Billerica/USA
providing the borrower with sufficient financial support to continue trading as
a going concern and to discharge its debt and liabilities as they fall due.


 


Dated:    September 7, 2009


 


 


	
  Bruker
  EAS GmbH

  	
   

  	
  Bruker
  BioSpin GmbH

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  /s/
  Burkhard Prause /s/ Peter Unvericht

  	
   

  	
  /s/
  Bernd Geweise /s/ Joerg Laukien

  



 


2

















 


	
   

  	
  Bruker
  Corporation

  
	
   

  	
  40
  Manning Road

  
	
   

  	
  Billerica,
  MA 01821 USA

  
	
   

  	
   

  
	
   

  	
  978-663-X1122
  phone

  
	
   

  	
  978-667-2917
  fax

  
	
   

  	
  www.bruker.com

  



 


William J. Knight


Chief
Financial Officer


 


September 3,
2009


 


Dear
Sirs,


 


We
will provide Bruker EAS GmbH with sufficient financial support to enable it to:


 


Continue
trading as a going concern;


 


Discharge
its debts and liabilities as they fall due


 


We
intend to provide such sufficient financial support to enable the company to
trade and to discharge its debts and liabilities until December 31st, 2010.


 


	
  Sincerely,

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  /s/
  William Knight

  	
   

  
	
  William
  J. Knight

  	
   

  
	
  Chief
  Financial Officer

  	
   

  



 


3